Rapport Therapeutics (RAPP) Change in Acquisitions & Divestments (2024 - 2026)

Rapport Therapeutics (RAPP) has reported Change in Acquisitions & Divestments for 3 consecutive years, with $10.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $178.0 million (down 13.53% YoY), while the FY2025 annual figure was $167.9 million, down 19.96% from the prior year.
• Change in Acquisitions & Divestments declined to $10.1 million in Q1 2026 per RAPP's latest filing, from $22.9 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $116.7 million in Q4 2024 and bottomed at $3.9 million in Q1 2024.
• Historically, Change in Acquisitions & Divestments has averaged $48.5 million across 3 years, with a median of $38.6 million in 2024.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 209.77% in 2025 and fell as far as 80.37% in 2025.
• Rapport Therapeutics' Change in Acquisitions & Divestments stood at $116.7 million in 2024, then tumbled by 80.37% to $22.9 million in 2025, then slumped by 56.04% to $10.1 million in 2026.
• Business Quant data shows RAPP's Change in Acquisitions & Divestments at $10.1 million in Q1 2026, $22.9 million in Q4 2025, and $45.0 million in Q3 2025.